Literature DB >> 18558480

Conformal and intensity-modulated radiotherapy for cervical cancer.

A Taylor1, M E B Powell.   

Abstract

Three-dimensional radiotherapy planning techniques, including conformal radiotherapy and intensity-modulated radiotherapy, have potential for improving outcomes in cervical cancer. Accurate target volume definition is essential in order to maximise normal tissue sparing while minimising the risk of a geographical miss. This reduction in toxicity provides the option of dose escalation, particularly with simultaneous integrated boost intensity-modulated radiotherapy. The evidence for the current use and potential applications of these techniques in the treatment of cervical cancer are discussed.

Entities:  

Mesh:

Year:  2008        PMID: 18558480     DOI: 10.1016/j.clon.2008.04.004

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  4 in total

Review 1.  Different strategies of treatment for uterine cervical carcinoma stage IB2-IIB.

Authors:  Lucas Minig; María Guadalupe Patrono; Nuria Romero; Juan Francisco Rodríguez Moreno; Jesús Garcia-Donas
Journal:  World J Clin Oncol       Date:  2014-05-10

2.  Significant impact on the oncologic outcomes with intensity modulated radiotherapy and conformational radiotherapy over conventional radiotherapy in cervix cancer patients treated with radiotherapy.

Authors:  Gustavo Arruda Viani; Fred Muller Dos Santos; Juliana Fernandes Pavoni
Journal:  Rep Pract Oncol Radiother       Date:  2020-06-07

3.  Distribution pattern of lymph node metastases and its implication in individualized radiotherapeutic clinical target volume delineation of regional lymph nodes in patients with stage IA to IIA cervical cancer.

Authors:  Xinglan Li; Yueju Yin; Xuigui Sheng; Xiaoyun Han; Li Sun; Chunhua Lu; Xiang Wang
Journal:  Radiat Oncol       Date:  2015-02-15       Impact factor: 3.481

4.  Postoperative pelvic intensity-modulated radiation therapy reduced the incidence of late gastrointestinal complications for uterine cervical cancer patients.

Authors:  Keisuke Tsuchida; Naoya Murakami; Tomoyasu Kato; Kae Okuma; Hiroyuki Okamoto; Tairo Kashihara; Kana Takahashi; Koji Inaba; Hiroshi Igaki; Yuko Nakayama; Takashi Nakano; Jun Itami
Journal:  J Radiat Res       Date:  2019-10-23       Impact factor: 2.724

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.